MMSM,Oncology,hematology,MedTwitter

Mashup Score: 2

Isatuximab Plus VRd Wins EU Approval for Newly Diagnosed, Transplant-Ineligible Multiple Myeloma - 21 hour(s) ago

The EMA’s CHMP has approved isatuximab in combination with VRd for transplant-ineligible patients with newly diagnosed multiple myeloma.

Source: www.onclive.com

Categories: General Medicine News, Oncologists1

Tweet Tweets with this article
- OncLive
  
  The @EMA_News's CHMP has approved isatuximab-irfc in combination with standard-of-care bortezomib, lenalidomide, and dexamethasone, for patients with newly diagnosed multiple myeloma who are ineligible for ASCT. #MMSM #Oncology #hematology #MedTwitter https://t.co/Cx2j4kPFqi https://t.co/U50dirsCAo